Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone treatment for adults with major depressive disorder who have not responded to at least two other antidepressants.
Health and Me on MSN9h
Can You Use Ketamine To Treat Depression?It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...
Also in the news, "renal denervation" shows promise as a treatment for high blood pressure; an estimated 17 million U.S. adults struggle with long-covid with no new treatments in sight; inequality ...
US Weekly on MSN7d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
LifeStance Health in Oklahoma is a provider of ketamine infusion therapy ... (esketamine), another therapeutic option for treatment-resistant depression. If you're suffering and aren't ...
While ketamine is celebrated as a breakthrough depression treatment, new research highlights a significant rise in its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback